Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  WHTCF | T.WELL.DB

WELL Health Technologies Corp. is a Canada-based practitioner-focused digital healthcare company. Its healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. Its business units include Canadian Patient Services, WELL Health USA Patient and Provider Services, and SaaS and Technology Services... see more

TSX:WELL - Post Discussion

View:
Post by retiredcf on Aug 18, 2024 1:55pm

Circle Medical

WELL announced today that Circle’s growth continues to be excellent and possibly accelerating. The last thing I would think of doing is selling that business if I owned part of it. They talk about unlocking shareholder value. I would prefer they buy more of Circle rather than selling their piece.

Circle now has a $100M revenue run rate and 55% margins. Business is good. We do not generally try and analyze company's capital allocations too much, however. Management knows the business of course more than we do. Executives have sold businesses before, and if they can re-coup capital and redeploy it for better returns (with more acquisitions at good valuations) then that could still be the right move for the company. Selling when things are going well, of course, also gets a better valuation. High debt could be holding back WELL's valuation, and thus a big asset sale could improve the share price. Either way, we would continue to view WELL as attractive overall. (5iResearch)
Comment by ahsh1kah on Aug 19, 2024 2:17pm
In Q2 Q&A, Shahbazi did't specify exactly what the strategic alternatives they have in mind for Circle Medical.   I as well prefer if they can acquire the rest of CR and then spin it off along WISP or even sepretely. 4 benefits of stock spinoff investment (Source: TSI Network)   1- Spinoffs are born with the proverbial “silver spoon.” Parent companies may devote great ...more  
Comment by Speedyg5344 on Aug 19, 2024 4:35pm
If you listen to the investor day audio, Circle's CEO opined it would be a 1 billion revenue business in 5 years 
Comment by ahsh1kah on Aug 20, 2024 9:53am
No, I didn't and I doubt  they can raise CR revenue 10x in 5 years, and if they managed, then Shahbazi should be nominated CEO of the year(s) All what I know is WELL future is bright and dark days are behind us.  The stock should no longer see 3 ish level and not even 4.25 ish.levels and if happens, don't hesitate to nibble more shares..
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities